Status
Conditions
Treatments
About
This study aims to identify the molecular genetic causes of the variability in development of calcific aortic valve disease in bicuspid and tricuspid aortic valves and their associated aortic dilation.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1,000 participants in 2 patient groups
Loading...
Central trial contact
Evynne Gartner; Simon C Robson, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal